J&J opens doors to U.K. innovation center; Renal denervation also fights ventricular arrhythmias;

 @FierceMedDev: For GenMark, more flu was good news in 2012. More | Follow @FierceMedDev

 @MarkHFierce: France's EyeTechCare, with $13M in new funding, will pursue U.S. approval of its glaucoma ultrasound medical device. More | Follow @MarkHFierce

 @DamianFierce: Luminex is on board to handle companion diagnostics for Merck's blockbuster hopeful Alzheimer's drug. More | Follow @DamianFierce

> Johnson & Johnson ($JNJ) has opened its U.K. innovation center, one of four planned around the world, in an effort to hunt for early-stage deals in pharma, devices and diagnostics. News

> In a Q&A with The Wall Street Journal, Covidien ($COV) CEO Jose Almeida discusses his company's decision to spin out its drug business and double down on medical devices. Article

> Echoing claims by Medtronic ($MDT) and St. Jude Medical ($STJ), a Greek study found that renal denervation therapy can lessen the burden of cardiac arrhythmias in patients with hypertension. Story

> Renal denervation has the unexpected side benefit of leading to fewer ventricular arrhythmias, according to a new study. Story

> Histogen will launch a joint venture with a cadre of medical device investors to adapt its fibroblast expertise to regenerative orthopedics. Story

> In a potential blow to CPAP devices, a new Australia study concludes that primary care doctors and nurses are just as capable at treating many sleep apnea cases. Story

Biotech News

 @FierceBiotech: Editor's corner: Will biotech grow in China and India without much VC help? More | Follow @FierceBiotech

 @JohnCFierce: Weird deal. Receptos gets a PhII-ready AbbVie antibody. AbbVie has option to co-dev, co-promote. If it's worth anything, why farm it out? | Follow @JohnCFierce

 @RyanMFierce: Takeda expanded a discovery alliance with Sripps Florida (pharma outsourcing more discovery work to academics.) Release | Follow @RyanMFierce

> J&J opens new innovation center in quest for more early-stage deals. Story

> Domain opens shop in China with plans to seed biotech startups, do deals. News

Pharma News

 @FiercePharma: India's Lupin joins hunt for branded products to beef up a generics portfolio. Has $1B to spend. Report | Follow @FiercePharma

 @EricPFierce: Bayer & Merck have weighed in on the big pay-for-delay case that the Supreme Court takes up this month. More | Follow @EricPFierce

> Bayer, Merck join fight against FTC in pay-for-delay case. More

> Merck hid Fosamax's links to femur fractures, lawyer says. More

Drug Delivery News

 @MichaelGFierce: Vaginal nanogel with bee venom could prevent HIV infection. Story | Follow @MichaelGFierce

> Terumo evens with Abbott's Xience in drug-eluting stent study. News

> Study: Artificial pancreas improves overnight care in diabetic children. Article

> Shape-shifting proteins could aid drug delivery for cancer, infections. More

> Celgene drops $13M on Presage's 3-D drug delivery platform. Report

> PolyPid, MIS Implants partner for drug delivering dental bone-filler. Item

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.